BHVN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BHVN has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company